Atlas Trials

Donor Stem Cell Transplant in Treating Patients With High-Risk Hematologic Cancer

Clinical trial NCT00818961 · TERMINATED

Trial details

NCT number
NCT00818961
Sponsor
Northside Hospital, Inc.
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
LeukemiaLymphomaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Diseases
Start date
2005-05-01
Primary completion
2011-03-01
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.